Big China Stakes Dim Our View of These 2 Funds
Vanguard Emerging Markets Stock Index Fund and iShares Core MSCI Emerging Markets ETF have large stakes in Chinese stocks, which holds them back from a higher rating.
Dan Sotiroff: Many of the broad, low-cost, index-tracking funds in Morningstar's diversified emerging-markets category have Analyst Ratings of Bronze. These include Vanguard Emerging Markets Stock Index Fund and iShares Core MSCI Emerging Markets ETF. The reason these low-cost options aren't rated higher is they have large stakes in Chinese stocks, with roughly one third of their portfolios dedicated to companies listed in China.
The Bronze rating isn't a reflection of expectations about the Chinese market. Instead, it shows a lower level of confidence in the ability of these funds to perform well within the category, because they don't diversify their country-specific risk as well as some of their actively managed competitors.
Daniel Sotiroff does not own shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.